Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Brands

Del Olmo banned from French competition

Euskaltel's Txema Del Olmo was hit with a three-year ban from competition in France by the Council for the Struggle Against Doping (CPLD) after testing positive for erythropoietin EPO, it was announced in Paris on Friday. Del Olmo failed a urine test for the red-blood-cell-boosting drug EPO during the 2001 Tour de France prologue. The ban applies only in France as CPLD is a French organization with no power to impose international penalties. "The analysis taken at Chatenay-Malabry and complying with the detection method of the national laboratory for doping tests revealed the presence

Don't miss a moment from Paris-Roubaix and Unbound Gravel, to the Giro d’Italia, Tour de France, Vuelta a España, and everything in between when you join Outside+.

By VeloNews Interactive wire services , Copyright AFP2002

Euskaltel’s Txema Del Olmo was hit with a three-year ban from competition in France by the Council for the Struggle Against Doping (CPLD) after testing positive for erythropoietin EPO, it was announced in Paris on Friday.

Del Olmo failed a urine test for the red-blood-cell-boosting drug EPO during the 2001 Tour de France prologue.

The ban applies only in France as CPLD is a French organization with no power to impose international penalties.

“The analysis taken at Chatenay-Malabry and complying with the detection method of the national laboratory for doping tests revealed the presence of erythropoietin,” a CPLD statement said on Friday. “The ‘B’ test confirmed this result.” The panel’s decision is in contrast to that of the Spanish national federation which exonerated Del Olmo on December 20 of last year, arguing that the threshold set, uniquely, by the Paris laboratory for the urine based test had no legal status.

Copyright AFP2002